The global astragalus root extract market, valued at USD 386.5 million in 2025, is forecast to grow to USD 566.6 million by 2035, at a CAGR of 3.9%, according to recent industry projections. The market is set to add an absolute dollar opportunity of USD 180.1 million over the forecast period, driven by the rising demand for immune-boosting nutraceuticals, broader integration of traditional medicinal ingredients, and rapid validation of clinical benefits in pharmaceutical-grade products.

With astragalus gaining prominence as a standardized herbal ingredient, its growing acceptance across dietary supplements, functional food, and pharmaceutical formulations reflects a structural shift toward proven natural wellness solutions. The market is projected to reach USD 472.4 million by 2030, registering an incremental addition of USD 85.9 million in the first half of the decade, followed by a moderately back-loaded growth path.

To Explore Detailed Market Data, Segment-Wise Forecasts, and Competitive Insights, Request Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-4736

Adaptogenic Demand and TCM Modernization Fuel Market Growth

The market’s progress is closely linked to rising global acceptance of immune-modulating herbs, particularly those backed by Traditional Chinese Medicine (TCM) principles. Astragalus, rich in polysaccharides and astragaloside IV, continues to gain regulatory support due to its validated role in cardiovascular health, stress adaptation, and immune system resilience.

Standardized extraction processes are accelerating pharmaceutical adoption, especially as manufacturers deploy potency-specific formulations for chronic inflammation management. These advances are positioning astragalus as a credible alternative to synthetic immune modulators, expanding its reach across clinical and consumer markets.

Powder Segment Dominates with 44% Share

In 2025, powdered astragalus root extract accounts for 44% of total market share, underpinned by cost efficiency and versatility in mass supplement production. Its stable shelf life, compatibility with capsules and tablets, and dosing precision make it the preferred choice for nutraceutical manufacturers.

• Widely used in pharmaceutical formulations due to potency standardization
• Increasing availability of certified organic, third-party tested variants
• Strong compliance with GMP manufacturing and global quality benchmarks

This format is expected to remain dominant, supported by tightening potency verification norms and international regulatory scrutiny.

Food & Beverage Applications Lead with 47% Share

Functional health products infused with botanicals are transforming consumer wellness trends worldwide. Astragalus extract holds 47% share in food & beverage applications, with demand accelerating across herbal teas, fortifying beverages, gummies, and dietary blends.

Consumer awareness of stress-linked disorders, obesity, and metabolic diseases is propelling herbal consumption beyond supplements. Adoption is significantly higher in Asia-Pacific and North America, where retail innovation and clean-label preferences shape product portfolios.

Top Growth Countries: China Leads with 6.2% CAGR

China dominates production with 156 GMP-certified facilities, generating 4.2 million kg of standardized extract in 2024, 60% of which targets global nutraceutical markets. India follows with strong Ayurvedic integration and a 28% YoY surge in standardized extract exports.

Germany is emerging as a pharmaceutical-grade import hub, while France’s phytotherapy ecosystem and the UK’s vegan clean-label segment support consistent demand growth.

Competitive Landscape: Standardized Technology Sets the Tone

The market remains moderately fragmented, yet competitive differentiation is shifting toward clinical validation and standardized extraction. Key leaders include:

• Nutragreen Biotechnology Co. and Xi’An Sanwei Biotechnology Co. – focus on GMP-certified export supplies
• Mountain Rose Herbs & Z Natural Foods LLC – strong organic, retail-driven positioning
• Martin Bauer Group & Naturex – pharmaceutical-grade standardization and research-led value creation

Regional players such as VidyaHerbs and Vita Forte Inc. capitalize on localized demand through cost leadership and quick turnaround sourcing for nutraceutical brands.

Key Companies Profiled are Nutragreen Biotechnology Co., Xi’An Sanwei Biotechnology Co., Mountain Rose Herbs, Z Natural Foods LLC, Martin Bauer Group, Naturex, Diana Group, Health Genesis, Vita Forte Inc., and VidyaHerbs

Information Source: https://www.futuremarketinsights.com/reports/astragalus-root-extract-market